Roflumilast — CAS 162401-32-3

Roflumilast is a high-purity Active Pharmaceutical Ingredient (API) classified under PDE4 Inhibitor / Anti-inflammatory Agent. Mediocon Inc manufactures GMP-compliant Roflumilast at its state-of-the-art facility in Aurangabad, Maharashtra, India, supplying pharmaceutical companies worldwide with consistent quality and full regulatory documentation.

• Chronic obstructive pulmonary disease (COPD)
• Phosphodiesterase-4 (PDE4) inhibition
• Reduction of COPD exacerbations
• Plaque psoriasis treatment

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support